SIA
DGX icon

SGL Investment Advisors’s Quest Diagnostics DGX Stock Holding History

SGL Investment Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.48M Sell
27,290
-968
-3% -$190K 2.24% 13
2026
Q1 		$5.36M Sell
28,258
-241
-0.8% -$46.8K 2.01% 19
2025
Q4 		$5.48M Buy
28,499
+450
+2% +$81.9K 2.19% 16
2025
Q3 		$5.02M Buy
28,049
+520
+2% +$92.3K 2.09% 16
2025
Q2 		$4.75M Buy
27,529
+814
+3% +$141K 2.26% 17
2025
Q1 		$4.7M Sell
26,715
-761
-3% -$125K 2.43% 12
2024
Q4 		$4.52M Buy
27,476
+906
+3% +$141K 2.28% 18
2024
Q3 		$4.17M Buy
+26,570
New +$3.97M 2.14% 18

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

SGL Investment Advisors's DGX Position: Q2 2026 in Review

SGL Investment Advisors reduced its Quest Diagnostics (DGX) stake by 3.4% in Q2 2026, selling an estimated $190K and leaving 27,290 shares worth $6.48M. The position accounts for 2.24% of the portfolio, ranked #13.

SGL Investment Advisors first reported a position in DGX in Q3 2024 and has held it in 8 quarters since. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • SGL Investment Advisors held 27,290 shares of Quest Diagnostics worth $6.48M as of Q2 2026.
  • SGL Investment Advisors sold 968 Quest Diagnostics shares in Q2 2026, an estimated $190K.
  • Quest Diagnostics made up 2.24% of SGL Investment Advisors's portfolio in Q2 2026, its #13 holding.
  • SGL Investment Advisors first reported a position in Quest Diagnostics in Q3 2024 and has held it in 8 quarters since.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on SGL Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.